- $14.48m
- $19.60m
- $52.68m
Iridex Corp Reports Results For The Quarter Ended In June: Earnings Summary
Brief: IRIDEX Announces Second Quarter 2022 Financial Results
Iridex Corp Expected To Post A Loss Of 15 Cents A Share: Earnings Preview
Brief: Iridex Obtains Regulatory Clearance For Cyclo G6® Glaucoma Platform In China
Iridex Corp Reports Results For The Quarter Ended In March: Earnings Summary
Iridex Corp Expected To Post A Loss Of 16 Cents A Share: Earnings Preview
Brief: IRIDEX Announces Appointment Of Beverly Huss To Its Board Of Directors
Iridex Corp Reports Results For The Quarter Ended In December: Earnings Summary
Brief: IRIDEX Announces Fourth Quarter And Full Year 2021 Financial Results
Iridex Corp Expected To Post A Loss Of 11 Cents A Share: Earnings Preview
Brief: Iridex Announces Preliminary Operational And Financial Results For Q4 And Full Year 2021
Brief: Iridex Announces Third Quarter 2021 Financial Results
Iridex Corp Expected To Post A Loss Of 14 Cents A Share: Earnings Preview
Iridex Corp Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Iridex Q2 Revenue Rose 116% To $13.4 Million
Iridex Corp Expected To Post A Loss Of 15 Cents A Share: Earnings Preview
Brief: Iridex Corp Files For Shelf Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Iridex Corp Reports Results For The Quarter Ended In March: Earnings Summary
Brief: Iridex Announces First Quarter 2021 Financial Results